Ann: Appendix 4C and Quarterly Update, page-105

Are you joking?

Start with these which marked the beginning. I haven't got time, but note there are more recent scientific studies, also the ONJCRI has done a lot of scientific work more recently in collaboration with PAA, despite the name, they are a highly respected public organisation. I

Bahrami, F., Morris, D. L., Rufener, L., & Pourgholami, M. H. (2014a). Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer. American Journal of Cancer Research, 4(5), 545–557.

Bahrami, F., Pourgholami, M. H., Mekkawy, A. H., Rufener, L., & Morris, D. L. (2014b). Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR/p70S6K signalling pathway. American Journal of Cancer Research, 4(5), 558–571.

Lecová, L., Stuchlíková, L., Prchal, L., & Skálová, L. (2014). Monepantel: the most studied new anthelmintic drug of recent years. Parasitology, 141(13), 1686–1698.